The Holy Grail of Orthopedic Surgery: Mesenchymal Stem Cells-Their Current Uses and Potential Applications.
Roberto Berebichez-FridmanRicardo Gómez-GarcíaJulio Granados-MontielEnrique Berebichez-FastlichtAnell Olivos-MezaJulio GranadosCristina VelasquilloClemente IbarraPublished in: Stem cells international (2017)
Only select tissues and organs are able to spontaneously regenerate after disease or trauma, and this regenerative capacity diminishes over time. Human stem cell research explores therapeutic regenerative approaches to treat various conditions. Mesenchymal stem cells (MSCs) are derived from adult stem cells; they are multipotent and exert anti-inflammatory and immunomodulatory effects. They can differentiate into multiple cell types of the mesenchyme, for example, endothelial cells, osteoblasts, chondrocytes, fibroblasts, tenocytes, vascular smooth muscle cells, and sarcomere muscular cells. MSCs are easily obtained and can be cultivated and expanded in vitro; thus, they represent a promising and encouraging treatment approach in orthopedic surgery. Here, we review the application of MSCs to various orthopedic conditions, namely, orthopedic trauma; muscle injury; articular cartilage defects and osteoarthritis; meniscal injuries; bone disease; nerve, tendon, and ligament injuries; spinal cord injuries; intervertebral disc problems; pediatrics; and rotator cuff repair. The use of MSCs in orthopedics may transition the practice in the field from predominately surgical replacement and reconstruction to bioregeneration and prevention. However, additional research is necessary to explore the safety and effectiveness of MSC treatment in orthopedics, as well as applications in other medical specialties.
Keyphrases
- mesenchymal stem cells
- stem cells
- umbilical cord
- cell therapy
- endothelial cells
- rotator cuff
- bone marrow
- vascular smooth muscle cells
- spinal cord
- minimally invasive
- healthcare
- randomized controlled trial
- skeletal muscle
- gene expression
- rheumatoid arthritis
- systematic review
- coronary artery bypass
- cell cycle arrest
- angiotensin ii
- spinal cord injury
- cell death
- young adults
- percutaneous coronary intervention
- trauma patients
- soft tissue
- atrial fibrillation
- induced pluripotent stem cells
- body composition
- bone mineral density
- climate change
- cell proliferation